Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years ...
Dec 27, 2016
2
177
An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent ...
Dec 19, 2016
0
3
Neuroblastoma is a rare cancer that develops in very early forms of nerve cells in the embryo or fetus, and it accounts for the most pediatric deaths for any tumor outside of the brain. The most lethal form of this tumor ...
Mar 7, 2016
0
810
A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves and is damaged in MS, according to a study released today that will be presented at ...
Apr 14, 2015
0
647
Treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might be able to interfere with the underlying cause of these events, ...
Mar 3, 2015
0
13
An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials.
Feb 24, 2015
0
7
Up to 5.3 million Americans currently have Alzheimer's disease, according to the U.S. Centers for Disease Control and Prevention, a number that is expected to triple by 2050 due to the aging of the population.
Dec 3, 2014
0
0
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug ...
Aug 21, 2014
0
0
(Medical Xpress)—A new research study at Northwestern Medicine and Rush University Medical Center is testing whether a new investigational treatment can slow the memory loss caused by Alzheimer's disease.
Jun 25, 2014
0
0
